Style | Citing Format |
---|---|
MLA | Seyedalinaghi S, et al.. "Ocular Manifestations of Covid-19: A Systematic Review of Current Evidence." Preventive Medicine Reports, vol. 38, no. , 2024, pp. -. |
APA | Seyedalinaghi S, Mehraeen E, Afzalian A, Dashti M, Ghasemzadeh A, Pashaei A, Masoud Afsahi A, Saeed Tamehri Zadeh S, Amiri Fard I, Vafaee A, Molla A, Shahidi R, Dadjou A, Amin Habibi M, Mirzapour P, Dadras O (2024). Ocular Manifestations of Covid-19: A Systematic Review of Current Evidence. Preventive Medicine Reports, 38(), -. |
Chicago | Seyedalinaghi S, Mehraeen E, Afzalian A, Dashti M, Ghasemzadeh A, Pashaei A, Masoud Afsahi A, et al.. "Ocular Manifestations of Covid-19: A Systematic Review of Current Evidence." Preventive Medicine Reports 38, no. (2024): -. |
Harvard | Seyedalinaghi S et al. (2024) 'Ocular Manifestations of Covid-19: A Systematic Review of Current Evidence', Preventive Medicine Reports, 38(), pp. -. |
Vancouver | Seyedalinaghi S, Mehraeen E, Afzalian A, Dashti M, Ghasemzadeh A, Pashaei A, et al.. Ocular Manifestations of Covid-19: A Systematic Review of Current Evidence. Preventive Medicine Reports. 2024;38():-. |
BibTex | @article{ author = {Seyedalinaghi S and Mehraeen E and Afzalian A and Dashti M and Ghasemzadeh A and Pashaei A and Masoud Afsahi A and Saeed Tamehri Zadeh S and Amiri Fard I and Vafaee A and Molla A and Shahidi R and Dadjou A and Amin Habibi M and Mirzapour P and Dadras O}, title = {Ocular Manifestations of Covid-19: A Systematic Review of Current Evidence}, journal = {Preventive Medicine Reports}, volume = {38}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Seyedalinaghi S AU - Mehraeen E AU - Afzalian A AU - Dashti M AU - Ghasemzadeh A AU - Pashaei A AU - Masoud Afsahi A AU - Saeed Tamehri Zadeh S AU - Amiri Fard I AU - Vafaee A AU - Molla A AU - Shahidi R AU - Dadjou A AU - Amin Habibi M AU - Mirzapour P AU - Dadras O TI - Ocular Manifestations of Covid-19: A Systematic Review of Current Evidence JO - Preventive Medicine Reports VL - 38 IS - SP - EP - PY - 2024 ER - |